We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA Takes Steps to Clarify Significant Human Tissue Questions

04 November 2015

Medical Device, Pharmaceutical, and Biotechnology Alert

On October 30, 2015, the Food and Drug Administration (FDA) issued a draft guidance document, Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products (the Homologous Use Guidance), discussing FDA’s interpretation of homologous use and how to apply regulatory criteria for human cells, tissues, and cellular and tissue-based products (HCT/Ps).

Read more: FDA Takes Steps to Clarify Significant Human Tissue Questions

The team

Loading data